Ohio State University Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.cancer.osu.edu

Clinical Trials

Quality of Life and Supportive Care Preferences Following Radiation Therapy in Prostate Cancer Survivors

Not Applicable

Completed

Conditions: Prostate Carcinoma

Interventions: Other: Undergo HRV and wear accelerometer to assess therapy complications
Procedure: Dual X-ray Absorptiometry
Other: Laboratory Biomarker Analysis
Other: Quality-of-Life Assessment
Other: Questionnaire Administration

First Posted Date: 2016-03-10

Last Posted Date: 2023-09-15

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 6

Registration Number: NCT02704377

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry

Recruiting

Conditions: Bone Neoplasms
Neoplasms, Connective and Soft Tissue

First Posted Date: 2016-02-09

Last Posted Date: 2024-03-08

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 1500

Registration Number: NCT02677961

Locations: 🇺🇸
Ohio State University, Columbus, Ohio, United States

Food Frequency Questionnaires in Estimating Food Nutrient Intake in Healthy Young Adults

Active, not recruiting

Conditions: Healthy Subject

Interventions: Other: Questionnaire Administration
Other: Laboratory Biomarker Analysis
Device: Spectroscopy

First Posted Date: 2015-11-20

Last Posted Date: 2024-11-04

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 100

Registration Number: NCT02610023

Locations: 🇺🇸
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States

Effects of Electronic Cigarette Use on the Lungs

Not Applicable

Completed

Conditions: Tobacco Use Disorder
E-cig User
Current Smoker
Never Smoker
Former Smoker

Interventions: Procedure: Bronchoscopy
Other: Laboratory Biomarker Analysis
Other: Electronic Cigarette
Other: Questionnaire Administration

First Posted Date: 2015-11-04

Last Posted Date: 2024-07-30

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 142

Registration Number: NCT02596685

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery

Not Applicable

Withdrawn

Conditions: Glioblastoma

Interventions: Procedure: Diffusion Weighted Imaging
Drug: Gadolinium
Other: Laboratory Biomarker Analysis
Procedure: Magnetic Resonance Imaging
Procedure: Perfusion Magnetic Resonance Imaging

First Posted Date: 2015-10-29

Last Posted Date: 2018-01-31

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Registration Number: NCT02590497

HDAC Inhibitor AR-42 and Pomalidomide in Treating Patients With Relapsed Multiple Myeloma

Phase 1

Completed

Conditions: Recurrent Plasma Cell Myeloma

Interventions: Drug: Dexamethasone
Drug: HDAC Inhibitor AR-42
Other: Laboratory Biomarker Analysis
Drug: Pomalidomide

First Posted Date: 2015-10-06

Last Posted Date: 2021-06-15

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 9

Registration Number: NCT02569320

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Hairy Cell Leukemia Patient Data Registry

Recruiting

Conditions: Leukemia, Other

First Posted Date: 2015-09-25

Last Posted Date: 2023-04-18

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 1000

Registration Number: NCT02560883

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Romidepsin Maintenance After Allogeneic Stem Cell Transplantation

Phase 1

Active, not recruiting

Conditions: Cutaneous T-cell Lymphoma
T-Prolymphocytic Leukemia
T-Large Granulocytic Leukemia
T-Lymphoblastic Leukemia/Lymphoma
Peripheral T-Cell Lymphoma

Interventions: Drug: Romidepsin
Drug: Busulfan
Drug: Fludarabine
Procedure: Stem Cell Transplant
Drug: Thymoglobulin

First Posted Date: 2015-07-31

Last Posted Date: 2024-10-29

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 23

Registration Number: NCT02512497

Locations: 🇺🇸
The Ohio State University Cancer Center, Columbus, Ohio, United States

Stereotactic Body Radiation Therapy and Transarterial Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Phase 1

Completed

Conditions: Child-Pugh Class A
Child-Pugh Class B
Stage IIIC Hepatocellular Carcinoma
Stage IIIA Hepatocellular Carcinoma
Stage IVA Hepatocellular Carcinoma
Stage IVB Hepatocellular Carcinoma
Stage IIIB Hepatocellular Carcinoma

Interventions: Other: Laboratory Biomarker Analysis
Radiation: Stereotactic Body Radiation Therapy
Procedure: Transarterial Chemoembolization

First Posted Date: 2015-07-24

Last Posted Date: 2021-10-13

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 16

Registration Number: NCT02507765

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Gentle Yoga and Dietary Counseling in Improving Physical Function and Quality of Life in Stage I-II Endometrial Cancer Survivors

Not Applicable

Completed

Conditions: Obesity
Endometrial Carcinoma

Interventions: Procedure: Gentle yoga therapy
Other: educational intervention
Other: counseling intervention
Other: quality-of-life assessment
Other: questionnaire administration

First Posted Date: 2015-06-08

Last Posted Date: 2023-09-15

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 16

Registration Number: NCT02465541

Locations: 🇺🇸
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy